These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28539171)

  • 1. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
    Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
    Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
    Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
    Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
    Xie H; Li M; Zheng Y
    Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes.
    Insin P; Prueksaritanond N
    Asian Pac J Cancer Prev; 2018 May; 19(5):1295-1302. PubMed ID: 29802690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
    Tian J; Liang Y; Qu P
    Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
    Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
    Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
    Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
    Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do endometrial cancer patients benefit from metformin intake?
    Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
    Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
    Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis.
    Han Y; Xie H; Liu Y; Gao P; Yang X; Shen Z
    Cardiovasc Diabetol; 2019 Jul; 18(1):96. PubMed ID: 31362743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and cancer-specific survival among breast, colorectal, or endometrial cancer patients: A nationwide data linkage study.
    Feng JL; Qin X
    Diabetes Res Clin Pract; 2021 May; 175():108755. PubMed ID: 33836207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin is associated with improved survival in endometrial cancer.
    Ko EM; Walter P; Jackson A; Clark L; Franasiak J; Bolac C; Havrilesky LJ; Secord AA; Moore DT; Gehrig PA; Bae-Jump V
    Gynecol Oncol; 2014 Feb; 132(2):438-42. PubMed ID: 24269517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
    Deng Y; Wang J; Li W; Xiong W; Wang X
    J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of metformin treatment in endometrial cancer: a meta-analysis.
    Gong H; Chen Y; Zhou D
    Pharmazie; 2020 Aug; 75(8):401-406. PubMed ID: 32758341
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
    Shuai Y; Li C; Zhou X
    Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis.
    Campbell JM; Bellman SM; Stephenson MD; Lisy K
    Ageing Res Rev; 2017 Nov; 40():31-44. PubMed ID: 28802803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
    Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
    Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.